Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine)

Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) is filed as Cold/Flu Relief. The sections below restate public label fields stored for this profile.

Class
Cold/Flu Relief
Generic name
aspirin-chlorpheniramine-phenylephrine
Route
ORAL
Dosage forms
Effervescent Tablet
Manufacturer
Bayer HealthCare LLC.

Approved uses

Uses · temporarily relieves these symptoms due to a cold with cough: · minor aches and pains · headache · cough · nasal and sinus congestion · sore throat · temporarily reduces fever

Warnings and precautions

Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Aspirin may cause a severe allergic reaction which may include: · hives · facial swelling · asthma (wheezing) · shock Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you • are age 60 or older • have had stomach ulcers or bleeding problems • take a blood thinning (anticoagulant) or steroid drug • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) • have 3 or more alcoholic drinks every day while using this product • take more or for a longer time than directed Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

Contraindications

Uses · temporarily relieves these symptoms due to a cold with cough: · minor aches and pains · headache · cough · nasal and sinus congestion · sore throat · temporarily reduces fever

Dosage and administration

Directions • adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water every 4 hours. Do not exceed 8 tablets in 24 hours or as directed by a doctor. • children under 12 years: do not use

Common questions

What is Alka-Seltzer Plus approved to treat?

According to its FDA label, Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) is approved for: Uses · temporarily relieves these symptoms due to a cold with cough: · minor aches and pains · headache · cough · nasal and sinus congestion · sore throat · temporarily reduces fever For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Alka-Seltzer Plus?

Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) belongs to the Cold/Flu Relief class of medications.

What form does Alka-Seltzer Plus come in?

The FDA label lists Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) as: oral route. Available strengths and packaging vary by manufacturer.

Does Alka-Seltzer Plus have a Boxed Warning?

Our ingest of the FDA label for Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does Alka-Seltzer Plus cost?

Public CMS NADAC pricing for Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Alka-Seltzer Plus currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine) in our latest ingest. Recall data can change daily — verify at FDA.gov.

Who makes Alka-Seltzer Plus?

The FDA label lists Bayer HealthCare LLC. as a labeler/manufacturer of Alka-Seltzer Plus (aspirin-chlorpheniramine-phenylephrine). Multiple firms may market generics of the same molecule.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…